Joshua Koo

Joshua Koo is an experienced professional in the healthcare and finance sectors, currently serving as a Mergers and Acquisitions Associate at Adragos Pharma since March 2023. Prior to this role, Joshua held positions as a Manager at EY-Parthenon from September 2021 to February 2023, and as a Medical Scientific Liaison at Pfizer from December 2020 to August 2021. Joshua began their career as an Analyst at Justpoint, a startup focused on improving the medical malpractice industry through AI technology, from January 2020 to March 2021. Additionally, Joshua was a Dean’s Summer Fellow at Columbia Business School in July 2020, after obtaining an MBA in Finance from the same institution. Earlier in Joshua's career, substantial medical experience was gained while working as a Medical Doctor at Parkway Shenton Pte Ltd and MOH Holdings Pte Ltd in Singapore from 2012 to 2019. Joshua holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the National University of Singapore.